Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. Its structure supports the design of modulators targeting receptors involved in neurological disorders. The trifluoromethoxy group enhances metabolic stability and membrane permeability, making it valuable in optimizing drug candidates for improved bioavailability and potency. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies to refine lead compounds.